Merck still in the market for deals in the $1B to $15B range, CEO says kdunleavy Thu, 02/01/2024 – 11:03 More: Merck still in the market for deals in the B to B range, CEO says Source: fierce
read moreDespite Roche’s sharp COVID sales decline, eye drug Vabysmo powers major revenue win, CEO says aliu Thu, 02/01/2024 – 10:50 More: Despite Roche's sharp COVID sales decline, eye drug Vabysmo powers major revenue win, CEO says Source: fierce
read moreSanofi expects RSV antibody to breach blockbuster status in 2024, even as supply hitch drags on fkansteiner Thu, 02/01/2024 – 10:02 More: Sanofi expects RSV antibody to breach blockbuster status in 2024, even as supply hitch drags on Source: fierce
read morePrescriptions ordered via the app are expected to save around 1.85 million hours in 2024 More: Millions of people to view digital prescriptions via the NHS app Source: News
read moreTumours with high mtDNA mutations more likely to respond to Opdivo More: Cancer treatment could identify patients most likely to respond to cancer drugs Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals